Clinical Trial Update: Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial comparing trabectedin to Adriamycin plus dacarbazine in patients with advanced solitary fibrous tumor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solitary Fibrous Tumor

Drugs mentioned

• Adriamycin (doxorubicin) (doxorubicin)
• Dacarbazine (dacarbazine)
• Trabectedin (trabectedin)

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Solitary Fibrous Tumors | Phase 2 | Status: COMPLETED